Latest Research in T-cell and B-cell Immunology

Top Research Topics in T-cell and B-cell Immunology

• T-cell and B-cell Immunology — 5 papers
• PARP inhibition in cancer therapy — 3 papers
• Immunotherapy and Immune Responses — 3 papers
• Cancer, Hypoxia, and Metabolism — 2 papers
• Acute Myeloid Leukemia Research — 2 papers
• RNA Research and Splicing — 2 papers
• Space Science and Extraterrestrial Life — 2 papers
• Iron Metabolism and Disorders — 1 papers
• Molecular Networks — 1 papers
• Signaling Pathways in Disease — 1 papers

Highest-Cited Papers

1. Antibody Fc receptor CD16a mediates natural killer cell activation via mechanotransduction of piconewton forces (2 citations)
2. Beyond poly(ADP-ribose) polymerase inhibition: emerging therapeutic strategies for germline BRCA1/2-mutated and PALB2-mutated breast cancers
3. Protocol for paired isolation and characterization of migrating cancer cell subpopulations in 3D hypoxic microenvironments
4. PGC1α-mediated upregulation of PHD2 represses HIF-signaling, limiting prostate cancer progression
5. Genetic Variants of NRAMP1 and Hepcidin ( HAMP ) in Cancer Patients Infected with Human Herpesvirus-6
6. Orchestra: Corroboration-Based Regulatory Candidate Discovery via Composed Bioinformatics MCP Agents
7. TET2 loss triggers ssDNA gap accumulation and heightened PARP inhibitor sensitivity
8. Investigating the role of FKBP10 in prostate cancer bone metastasis through osteo-mimicry and the collagen crosslinking axis
9. How the hunt for human retroviruses led to the discovery of interleukin-2 and a path to immunotherapy
10. Baseline T-helper-related immune measures and subsequent infectious events in children with newly diagnosed malignancies: an exploratory prospective cohort study
11. The DNA / RNA Helicase SETX Maintains R‐Loop Homeostasis to Promote Chemoresistance in Ovarian Cancer
12. Docosahexaenoic Acid Enhances the Cytotoxic Effects of Enzalutamide and the PARP Inhibitor in Castration-Resistant Prostate Cancer Cell Lines
13. CD73 disruption with tumor-specific CRISPR/Cas9 nanoparticles reduces adenosine-mediated immunosuppression and amplifies response to chemotherapy
14. In vitro differentiation and phenotypic profiling of Langerhans cell subsets derived from human peripheral blood monocytes
15. Protein Expression Dynamics in Breast Cancer Cells Exposed to Nano-Encapsulated Tarin, the Taro Lectin
16. A Network-Structured Bayesian Hierarchical Model for Sparse Mutation-Drug Response Associations: Application to Cancer Pharmacogenomics
17. PANoptosis-related HLTF promotes prostate cancer progression and serves as a potential therapeutic target
18. The many roads to B cell memory
19. Overcoming Resistance to PARP Inhibitors in BRCA-Mutated Cancers: Mechanisms and Therapeutic Strategies
20. Integrative proteomics reveals MSH6 to modulate PARP inhibitor sensitivity in BRCA1/2-proficient ovarian cancer